Close

Production & Manufacturing

Johnson Matthey and Rennovia announce licence agreement with ADM for glucaric acid production technology

Johnson Matthey, a global specialty chemicals company and provider of advanced process technologies, and Rennovia Inc., a privately held company that develops novel catalysts and processes for the cost advantaged production of chemical products from renewable feedstocks. ...

Aldevron expands manufacturing scale and implements single-use fermentation technology

Aldevron, a leading biotechnology contract manufacturing and development organization, is now using a 30-liter single-use fermentation system for manufacturing nucleic acids and proteins. "Aldevron single-use fermentation (SUF) technology allows for rapid turnover of the fermentor between...

Mundipharma, Helsinn Expand Licensing and Distribution Agreements for Leading Anti-emetic Products

Mundipharma and Helsinn Group have expanded their collaboration, signing amendments to licensing and distribution agreements for anti-emetic prophylactic agents ALOXI® and AKYNZEO® to cover a host of additional markets. Chemotherapy induced nausea and vomiting (CINV) is...

AMAG and Endoceutics Enter Into an Exclusive U.S. License Agreement for Intrarosa  (Prasterone)

AMAG Pharmaceuticals, Inc. and Endoceutics, Inc. announced that they have entered into an exclusive license agreement that provides AMAG with U.S. commercial rights to Intrarosaâ„¢ (prasterone). Intrarosa is the only FDA-approved, locally administered, daily, non-estrogen product...

Immune Pharmaceuticals Enters a Research Partnership to Develop Mono and Bispecific Antibodies  

Immune Pharmaceuticals Inc , a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of immuno-inflammatory diseases and cancers. Announced that it has entered an exclusive sub-license agreement with SATT Sud-Est, a French Technology Transfer Office,...

Catalent To Develop Softgel Capsules For JOT’s Leading Orphan Disease Candidates

Catalent Pharma Solutions, the leading global provider of advanced delivery technologies and development solutions for drugs, biologics and consumer health products. Announced that it is to evaluate Jupiter Orphan Therapeutics, Inc.’s (JOT) novel formulation of resveratrol,...

Prokarium and Probiomed Scale Up Manufacture of Oral Vaccines

Biotech firms Prokarium and Probiomed have announced a collaboration to scale-up the manufacture of orally administered vaccines in a formulation that would enable stability at 40°C for several weeks. The first vaccine to be manufactured will...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Must read